Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2005-07, Vol.49 (7), p.2828-2833 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2833 |
|---|---|
| container_issue | 7 |
| container_start_page | 2828 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 49 |
| creator | HERZMANN, C ARASTEH, K MURPHY, R. L SCHULBIN, H KRECKEL, P DRAUZ, D SCHINAZI, R. F BEARD, A CARTEE, L OTTO, M. J |
| description | Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.49.7.2828-2833.2005 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_15980356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17561172</sourcerecordid><originalsourceid>FETCH-LOGICAL-h351t-6a06bff81d01dcd0356264b07124023bc0caf5166d315003936dfebc0b359a7b3</originalsourceid><addsrcrecordid>eNpVUstu1DAUjRCITgd-AcICVMR4aseJk2yQRkNLR6qgUgtb68axG0Nil9iZMqxYsuZHkPoLSCz5iH4Jnunw2vjK5xyfe3R9o-ghwVNCkmJ_NptP03KaT5MiKVBSUDpNMM5uRSOCywKxrGS3oxHGjKG0wOlOtOvcOxzuWYnvRjskKwtMMzaKfpyCkn41iU8a6DsQ9r020mvhJjGYOj5QSgsQq9iqeO_Z_vWXr0_RzyuUXH--mtBwoBe6lvbjCmXosB1sb9EGPWt0eOR1HcziS-2bYARL3UvzaWN76mE5bEht4pnxgfG9DQJo0Sv4_m0p46OhAxMvum4wtpYhhZYm5Hir-8GhhVFSeFnHJ-AD7t296I6C1sn72zqO3hwenM2P0PHrl4v57Bg1NCMeMcCsUqogNSa1qNcjSFha4ZwkKU5oJbAAlRHGakoyjGlJWa1kgCualZBXdBw9v_G9GKpO1iL0Dpn5Ra876Ffcgub_M0Y3_NwuOSGsYCwJBk-2Br39MEjneaedkG0LRtrBcZJnjJB8LXzwb6c_LX5_XRA83grACWhVD0Zo91fHSlLgsBnj6NGNrtHnzWWYNAfXcQDB05LnfL1A9Bdj4L1O</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17561172</pqid></control><display><type>article</type><title>Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>HERZMANN, C ; ARASTEH, K ; MURPHY, R. L ; SCHULBIN, H ; KRECKEL, P ; DRAUZ, D ; SCHINAZI, R. F ; BEARD, A ; CARTEE, L ; OTTO, M. J</creator><creatorcontrib>HERZMANN, C ; ARASTEH, K ; MURPHY, R. L ; SCHULBIN, H ; KRECKEL, P ; DRAUZ, D ; SCHINAZI, R. F ; BEARD, A ; CARTEE, L ; OTTO, M. J</creatorcontrib><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.49.7.2828-2833.2005</identifier><identifier>PMID: 15980356</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Administration, Oral ; Adult ; Anti-HIV Agents - administration & dosage ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - pharmacokinetics ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral Agents ; Benzoxazines ; Biological and medical sciences ; Drug Therapy, Combination ; HIV Infections - drug therapy ; HIV Infections - virology ; HIV-1 - drug effects ; Human immunodeficiency virus 1 ; Humans ; Medical sciences ; Middle Aged ; Oxazines - therapeutic use ; Pharmacology. Drug treatments ; Plasma - metabolism ; Reverse Transcriptase Inhibitors - administration & dosage ; Reverse Transcriptase Inhibitors - adverse effects ; Reverse Transcriptase Inhibitors - pharmacokinetics ; Reverse Transcriptase Inhibitors - therapeutic use ; RNA, Viral - blood ; Stavudine - therapeutic use ; Urine - chemistry ; Zalcitabine - administration & dosage ; Zalcitabine - adverse effects ; Zalcitabine - analogs & derivatives ; Zalcitabine - pharmacokinetics ; Zalcitabine - therapeutic use</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2828-2833</ispartof><rights>2005 INIST-CNRS</rights><rights>Copyright © 2005, American Society for Microbiology 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168662/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1168662/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16918028$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15980356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HERZMANN, C</creatorcontrib><creatorcontrib>ARASTEH, K</creatorcontrib><creatorcontrib>MURPHY, R. L</creatorcontrib><creatorcontrib>SCHULBIN, H</creatorcontrib><creatorcontrib>KRECKEL, P</creatorcontrib><creatorcontrib>DRAUZ, D</creatorcontrib><creatorcontrib>SCHINAZI, R. F</creatorcontrib><creatorcontrib>BEARD, A</creatorcontrib><creatorcontrib>CARTEE, L</creatorcontrib><creatorcontrib>OTTO, M. J</creatorcontrib><title>Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Administration, Oral</subject><subject>Adult</subject><subject>Anti-HIV Agents - administration & dosage</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - pharmacokinetics</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral Agents</subject><subject>Benzoxazines</subject><subject>Biological and medical sciences</subject><subject>Drug Therapy, Combination</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - drug effects</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Oxazines - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasma - metabolism</subject><subject>Reverse Transcriptase Inhibitors - administration & dosage</subject><subject>Reverse Transcriptase Inhibitors - adverse effects</subject><subject>Reverse Transcriptase Inhibitors - pharmacokinetics</subject><subject>Reverse Transcriptase Inhibitors - therapeutic use</subject><subject>RNA, Viral - blood</subject><subject>Stavudine - therapeutic use</subject><subject>Urine - chemistry</subject><subject>Zalcitabine - administration & dosage</subject><subject>Zalcitabine - adverse effects</subject><subject>Zalcitabine - analogs & derivatives</subject><subject>Zalcitabine - pharmacokinetics</subject><subject>Zalcitabine - therapeutic use</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUstu1DAUjRCITgd-AcICVMR4aseJk2yQRkNLR6qgUgtb68axG0Nil9iZMqxYsuZHkPoLSCz5iH4Jnunw2vjK5xyfe3R9o-ghwVNCkmJ_NptP03KaT5MiKVBSUDpNMM5uRSOCywKxrGS3oxHGjKG0wOlOtOvcOxzuWYnvRjskKwtMMzaKfpyCkn41iU8a6DsQ9r020mvhJjGYOj5QSgsQq9iqeO_Z_vWXr0_RzyuUXH--mtBwoBe6lvbjCmXosB1sb9EGPWt0eOR1HcziS-2bYARL3UvzaWN76mE5bEht4pnxgfG9DQJo0Sv4_m0p46OhAxMvum4wtpYhhZYm5Hir-8GhhVFSeFnHJ-AD7t296I6C1sn72zqO3hwenM2P0PHrl4v57Bg1NCMeMcCsUqogNSa1qNcjSFha4ZwkKU5oJbAAlRHGakoyjGlJWa1kgCualZBXdBw9v_G9GKpO1iL0Dpn5Ra876Ffcgub_M0Y3_NwuOSGsYCwJBk-2Br39MEjneaedkG0LRtrBcZJnjJB8LXzwb6c_LX5_XRA83grACWhVD0Zo91fHSlLgsBnj6NGNrtHnzWWYNAfXcQDB05LnfL1A9Bdj4L1O</recordid><startdate>20050701</startdate><enddate>20050701</enddate><creator>HERZMANN, C</creator><creator>ARASTEH, K</creator><creator>MURPHY, R. L</creator><creator>SCHULBIN, H</creator><creator>KRECKEL, P</creator><creator>DRAUZ, D</creator><creator>SCHINAZI, R. F</creator><creator>BEARD, A</creator><creator>CARTEE, L</creator><creator>OTTO, M. J</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20050701</creationdate><title>Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients</title><author>HERZMANN, C ; ARASTEH, K ; MURPHY, R. L ; SCHULBIN, H ; KRECKEL, P ; DRAUZ, D ; SCHINAZI, R. F ; BEARD, A ; CARTEE, L ; OTTO, M. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h351t-6a06bff81d01dcd0356264b07124023bc0caf5166d315003936dfebc0b359a7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Anti-HIV Agents - administration & dosage</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - pharmacokinetics</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral Agents</topic><topic>Benzoxazines</topic><topic>Biological and medical sciences</topic><topic>Drug Therapy, Combination</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - drug effects</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Oxazines - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasma - metabolism</topic><topic>Reverse Transcriptase Inhibitors - administration & dosage</topic><topic>Reverse Transcriptase Inhibitors - adverse effects</topic><topic>Reverse Transcriptase Inhibitors - pharmacokinetics</topic><topic>Reverse Transcriptase Inhibitors - therapeutic use</topic><topic>RNA, Viral - blood</topic><topic>Stavudine - therapeutic use</topic><topic>Urine - chemistry</topic><topic>Zalcitabine - administration & dosage</topic><topic>Zalcitabine - adverse effects</topic><topic>Zalcitabine - analogs & derivatives</topic><topic>Zalcitabine - pharmacokinetics</topic><topic>Zalcitabine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HERZMANN, C</creatorcontrib><creatorcontrib>ARASTEH, K</creatorcontrib><creatorcontrib>MURPHY, R. L</creatorcontrib><creatorcontrib>SCHULBIN, H</creatorcontrib><creatorcontrib>KRECKEL, P</creatorcontrib><creatorcontrib>DRAUZ, D</creatorcontrib><creatorcontrib>SCHINAZI, R. F</creatorcontrib><creatorcontrib>BEARD, A</creatorcontrib><creatorcontrib>CARTEE, L</creatorcontrib><creatorcontrib>OTTO, M. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HERZMANN, C</au><au>ARASTEH, K</au><au>MURPHY, R. L</au><au>SCHULBIN, H</au><au>KRECKEL, P</au><au>DRAUZ, D</au><au>SCHINAZI, R. F</au><au>BEARD, A</au><au>CARTEE, L</au><au>OTTO, M. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2005-07-01</date><risdate>2005</risdate><volume>49</volume><issue>7</issue><spage>2828</spage><epage>2833</epage><pages>2828-2833</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>15980356</pmid><doi>10.1128/AAC.49.7.2828-2833.2005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2005-07, Vol.49 (7), p.2828-2833 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_pubmed_primary_15980356 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Administration, Oral Adult Anti-HIV Agents - administration & dosage Anti-HIV Agents - adverse effects Anti-HIV Agents - pharmacokinetics Anti-HIV Agents - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral Agents Benzoxazines Biological and medical sciences Drug Therapy, Combination HIV Infections - drug therapy HIV Infections - virology HIV-1 - drug effects Human immunodeficiency virus 1 Humans Medical sciences Middle Aged Oxazines - therapeutic use Pharmacology. Drug treatments Plasma - metabolism Reverse Transcriptase Inhibitors - administration & dosage Reverse Transcriptase Inhibitors - adverse effects Reverse Transcriptase Inhibitors - pharmacokinetics Reverse Transcriptase Inhibitors - therapeutic use RNA, Viral - blood Stavudine - therapeutic use Urine - chemistry Zalcitabine - administration & dosage Zalcitabine - adverse effects Zalcitabine - analogs & derivatives Zalcitabine - pharmacokinetics Zalcitabine - therapeutic use |
| title | Safety, Pharmacokinetics, and Efficacy of (+/−)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naïve Human Immunodeficiency Virus-Infected Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T00%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety,%20Pharmacokinetics,%20and%20Efficacy%20of%20(+/%E2%88%92)-%CE%B2-2%E2%80%B2,3%E2%80%B2-Dideoxy-5-Fluoro-3%E2%80%B2-Thiacytidine%20with%20Efavirenz%20and%20Stavudine%20in%20Antiretroviral-Na%C3%AFve%20Human%20Immunodeficiency%20Virus-Infected%20Patients&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=HERZMANN,%20C&rft.date=2005-07-01&rft.volume=49&rft.issue=7&rft.spage=2828&rft.epage=2833&rft.pages=2828-2833&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.49.7.2828-2833.2005&rft_dat=%3Cproquest_pubme%3E17561172%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17561172&rft_id=info:pmid/15980356&rfr_iscdi=true |